Calpains are ubiquitous intracellular calcium- and thiol-dependent proteases. Their over activation, resulting in the degradation of various substrates, has been implicated in a number of cardiovascular and neurological disorders. Here, we present the first structural characterization of LSEAL pentapeptide, a potent calpain inhibitor, bound to the calmodulin-like domain of calpain. Our in vitro binding data supports the idea that domains other than calpain’s active site may be suitable targets for future development of therapeutic agents to be used to treat heart attack, traumatic brain injuries or a variety of neurodegenerative conditions, such as ischemic stroke.
Related links
Details
Title
NMR structural characterization of the penta-peptide calpain inhibitor
Publication Details
FEBS Letters, Vol.583, pp.135-140
Resource Type
Journal article
Publisher
John Wiley & Sons Ltd.; United Kingdom
Series
583
Copyright
2008 Federation of European Biochemical Societies
Identifiers
WOS:000261949200024; 99380090784506600
Academic Unit
Hal Marcus College of Science and Engineering ; Biology